Shi, C.; Su, C.; Cen, L.; Han, L.; Tang, J.; Wang, Z.; Shi, X.; Ju, D.; Cao, Y.; Zhu, H.
Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus. Biomedicines 2023, 11, 1160.
https://doi.org/10.3390/biomedicines11041160
AMA Style
Shi C, Su C, Cen L, Han L, Tang J, Wang Z, Shi X, Ju D, Cao Y, Zhu H.
Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus. Biomedicines. 2023; 11(4):1160.
https://doi.org/10.3390/biomedicines11041160
Chicago/Turabian Style
Shi, Chenchen, Chang Su, Lifeng Cen, Lei Han, Jianguo Tang, Zetian Wang, Xunlong Shi, Dianwen Ju, Yiou Cao, and Haiyan Zhu.
2023. "Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus" Biomedicines 11, no. 4: 1160.
https://doi.org/10.3390/biomedicines11041160
APA Style
Shi, C., Su, C., Cen, L., Han, L., Tang, J., Wang, Z., Shi, X., Ju, D., Cao, Y., & Zhu, H.
(2023). Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus. Biomedicines, 11(4), 1160.
https://doi.org/10.3390/biomedicines11041160
